Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

TD Cowen's Rating of Regeneron Pharmaceuticals on 10/21/2026

On October 21, 2026, TD Cowen updated its outlook on Regeneron Pharmaceuticals (NASDAQ:REGN) with the action "Boost Price Target", setting a price target of $980.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from TD Cowen

DateCompanyAction
10/22/2026
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
Boost Price Target
10/22/2026
Crown Castle Inc. stock logo
CCI
Crown Castle
Boost Price Target
10/22/2026
CSX Corporation stock logo
CSX
CSX
Reiterated Rating
10/22/2026
Phillips 66 stock logo
PSX
Phillips 66
Boost Price Target
10/22/2026
Marathon Petroleum Corporation stock logo
MPC
Marathon Petroleum
Boost Price Target
10/22/2026
Delek US Holdings, Inc. stock logo
DK
Delek US
Boost Price Target
More Ratings From TD Cowen